Systemic Immunotherapy for the Treatment of Brain Metastases

por Cohen, Justine V., Kluger, Harriet M.
Publicado 2016

Drug targets and predictive biomarkers in the management of metastatic melanoma

por Thumar, Jaykumar, Giesen, Eva, Kluger, Harriet M
Publicado 2012

Anti-PD-1 Therapy-Associated Perforating Colitis

por Celli, Romulo, Kluger, Harriet M., Zhang, Xuchen
Publicado 2018

Agonistic CD40 Antibodies in Cancer Treatment

por Djureinovic, Dijana, Wang, Meina, Kluger, Harriet M.
Publicado 2021

Characterizing disease states from topological properties of transcriptional regulatory networks

por Tuck, David P, Kluger, Harriet M, Kluger, Yuval
Publicado 2006

MEK targeting in N-RAS mutated metastatic melanoma

por Thumar, Jaykumar, Shahbazian, David, Aziz, Saadia A, Jilaveanu, Lucia B, Kluger, Harriet M
Publicado 2014

Quantitative analysis of CMTM6 expression in tumor microenvironment in metastatic melanoma and association with outcome on immunotherapy

por Martinez-Morilla, Sandra, Zugazagoitia, Jon, Wong, Pok Fai, Kluger, Harriet M., Rimm, David L.
Publicado 2020

NY-ESO-1 as a potential immunotherapeutic target in renal cell carcinoma

por Giesen, Eva, Jilaveanu, Lucia B., Parisi, Fabio, Kluger, Yuval, Camp, Robert L., Kluger, Harriet M.
Publicado 2014

Vascularity of primary and metastatic renal cell carcinoma specimens

por Aziz, Saadia A, Sznol, Joshua, Adeniran, Adebowale, Colberg, John W, Camp, Robert L, Kluger, Harriet M
Publicado 2013

MET Expression in Primary and Metastatic Clear Cell Renal Cell Carcinoma: Implications of Correlative Biomarker Assessment to MET Pathway Inhibitors

por Shuch, Brian, Falbo, Ryan, Parisi, Fabio, Adeniran, Adebowale, Kluger, Yuval, Kluger, Harriet M., Jilaveanu, Lucia B.
Publicado 2015

Expression patterns and prognostic value of Bag-1 and Bcl-2 in breast cancer

por Nadler, Yasmine, Camp, Robert L, Giltnane, Jennifer M, Moeder, Christopher, Rimm, David L, Kluger, Harriet M, Kluger, Yuval
Publicado 2008

Benefits of biomarker selection and clinico-pathological covariate inclusion in breast cancer prognostic models

por Parisi, Fabio, González, Ana M, Nadler, Yasmine, Camp, Robert L, Rimm, David L, Kluger, Harriet M, Kluger, Yuval
Publicado 2010

Expression of drug targets in primary and matched metastatic renal cell carcinoma tumors

por Aziz, Saadia A, Sznol, Joshua A, Adeniran, Adebowale, Parisi, Fabio, Kluger, Yuval, Camp, Robert L, Kluger, Harriet M
Publicado 2013

Multiplex quantitative analysis of cancer-associated fibroblasts and immunotherapy outcome in metastatic melanoma

por Wong, Pok Fai, Wei, Wei, Gupta, Swati, Smithy, James W., Zelterman, Daniel, Kluger, Harriet M., Rimm, David L.
Publicado 2019

Perilesional edema in brain metastases: potential causes and implications for treatment with immune therapy

por Tran, Thuy T., Mahajan, Amit, Chiang, Veronica L., Goldberg, Sarah B., Nguyen, Don X., Jilaveanu, Lucia B., Kluger, Harriet M.
Publicado 2019

MET Inhibition in Clear Cell Renal Cell Carcinoma

por Xie, Zuoquan, Lee, Young H., Boeke, Marta, Jilaveanu, Lucia B., Liu, Zongzhi, Bottaro, Donald P., Kluger, Harriet M., Shuch, Brian
Publicado 2016

Association between immune-mediated adverse events and efficacy in metastatic non-small-cell lung cancer patients treated with durvalumab and tremelimumab

por Dey, Agnish, Austin, Matthew, Kluger, Harriet M., Trunova, Nataliya, Mann, Helen, Shire, Norah, Morgan, Claire, Zhou, Diansong, Mugundu, Ganesh M.
Publicado 2022

Society for Immunotherapy of Cancer (SITC) checkpoint inhibitor resistance definitions: efforts to harmonize terminology and accelerate immuno-oncology drug development

por Tawbi, Hussein A, Sullivan, Ryan J, Feltquate, David, LaVallee, Theresa, Rizvi, Naiyer A, Sharon, Elad, Sosman, Jeffrey, Kluger, Harriet M
Publicado 2023

Incidence of the V600K mutation among melanoma patients with BRAF mutations, and potential therapeutic response to the specific BRAF inhibitor PLX4032

por Rubinstein, Jill C, Sznol, Mario, Pavlick, Anna C, Ariyan, Stephan, Cheng, Elaine, Bacchiocchi, Antonella, Kluger, Harriet M, Narayan, Deepak, Halaban, Ruth
Publicado 2010

Characterization and targeting of phosphatidylinositol-3 kinase (PI3K) and mammalian target of rapamycin (mTOR) in renal cell cancer

por Elfiky, Aymen A, Aziz, Saadia A, Conrad, Patricia J, Siddiqui, Summar, Hackl, Wolfgang, Maira, Michel, Robert, Camp L, Kluger, Harriet M
Publicado 2011